Cargando…

WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease

Clinical trials to improve day-to-day function in Huntington disease (HD) require accurate outcome measures. The DSM-5 recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for use in neuropsychiatric disorders. The DSM-5 also states proxy measures may be useful when c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Downing, Nancy R, Kim, Ji-In, Williams, Janet K, Long, Jeffrey D, Mills, James A, Paulsen, Jane S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350592/ https://www.ncbi.nlm.nih.gov/pubmed/24327189 http://dx.doi.org/10.1038/ejhg.2013.275

Ejemplares similares

Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease
por: Kim, Ji-In, et al.
Publicado: (2015)

Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease
por: Harrington, Deborah L, et al.
Publicado: (2014)

Is There an Association of Physical Activity with Brain Volume, Behavior, and Day-to-day Functioning? A Cross Sectional Design in Prodromal and Early Huntington Disease
por: Wallace, McKenzie, et al.
Publicado: (2016)

Measuring disability in multiple sclerosis: the WHODAS 2.0
por: Young, Carolyn A., et al.
Publicado: (2023)

Assessment of Day-to-Day Functioning in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Association between Age and Striatal Volume Stratified by CAG Repeat Length in Prodromal Huntington Disease
por: Aylward, Elizabeth, et al.
Publicado: (2011)

Is WHODAS 2.0 Useful for Colorectal Cancer Survivors?
por: Lee, Hyun Haeng, et al.
Publicado: (2017)

Assessment of Cognitive Symptoms in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington’s Disease
por: Liu, Jingyu, et al.
Publicado: (2018)

Patterns of Co-Occurring Gray Matter Concentration Loss across the Huntington Disease Prodrome
por: Ciarochi, Jennifer Ashley, et al.
Publicado: (2016)

Self Reports of Day-to-Day Function in a Small Cohort of People with Prodromal and Early HD
por: Williams, Janet, et al.
Publicado: (2011)

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study
por: Reed, Eric R., et al.
Publicado: (2018)

Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Measurement Invariance of the WHODAS 2.0 in a Population-Based Sample of Youth
por: Kimber, Melissa, et al.
Publicado: (2015)

Assessment of Motor Symptoms and Functional Impact in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Comparison of the responsiveness of the WOMAC and the 12-item WHODAS 2.0 in patients with Kashin–Beck disease
por: Yang, Lei, et al.
Publicado: (2020)

WHODAS 2.0 as a Measure of Severity of Illness: Results of a FLDA Analysis
por: Sedano-Capdevila, Alba, et al.
Publicado: (2018)

WHODAS 2.0-BO: normative data for the assessment of disability in older adults
por: Ferrer, Michele Lacerda Pereira, et al.
Publicado: (2019)

Psychometric properties and validation of the polish version of the 12-item WHODAS 2.0
por: Ćwirlej-Sozańska, Agnieszka, et al.
Publicado: (2020)

Effects of Hearing Disability on the Employment Status Using WHODAS 2.0 in Taiwan
por: Chao, Pin-Zhir, et al.
Publicado: (2020)

Non-Verbal and Verbal Fluency in Prodromal Huntington's Disease
por: Robins Wahlin, Tarja-Brita, et al.
Publicado: (2015)

Neuropsychiatric Burden in Huntington’s Disease
por: Paoli, Ricardo Augusto, et al.
Publicado: (2017)

WHODAS 2.0 Can Predict Institutionalization among Patients with Traumatic Brain Injury
por: Huang, Shih-Wei, et al.
Publicado: (2019)

Psychometric evaluation of the WHODAS 2.0 and prevalence of disability in a Swedish general population
por: Norén, Paulina, et al.
Publicado: (2023)

Measurement of patient reported disability using WHODAS 2.0 before and after surgical intervention in Madagascar
por: White, Michelle C., et al.
Publicado: (2018)

Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials
por: Langbehn, Douglas R., et al.
Publicado: (2020)

Comparison of Three Quality of Life Instruments in Lymphatic Filariasis: DLQI, WHODAS 2.0, and LFSQQ
por: Thomas, Cristina, et al.
Publicado: (2014)

Using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) for Predicting Institutionalization of Patients With Dementia in Taiwan
por: Huang, Shih-Wei, et al.
Publicado: (2015)

Prodromal Huntington Disease as a Model for Functional Compensation of Early Neurodegeneration
por: Malejko, Kathrin, et al.
Publicado: (2014)

Rate of torque development and striatal shape in individuals with prodromal Huntington's disease
por: Cruickshank, Travis, et al.
Publicado: (2020)

Psychometric Properties of the Polish Version of the 36-Item WHODAS 2.0 in Patients with Low Back Pain
por: Ćwirlej-Sozańska, Agnieszka, et al.
Publicado: (2020)

Clinical validity of the 12-item WHODAS-2.0 in a naturalistic sample of outpatients with psychotic disorders
por: Holmberg, Christopher, et al.
Publicado: (2021)

Psychometric properties of the Polish version of the 36-item WHODAS 2.0 in patients with hip and knee osteoarthritis
por: Bejer, Agnieszka, et al.
Publicado: (2021)

Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT‐HD
por: Long, Jeffrey D., et al.
Publicado: (2015)

Neuropsychiatric Disturbance in Huntington’s Disease: Approach to Management
por: Jay, J., et al.
Publicado: (2022)

Support for the higher-order factor structure of the WHODAS 2.0 self-report version in a Dutch outpatient psychiatric setting
por: Williams, Guido L., et al.
Publicado: (2021)

Using WHODAS 2.0 to Assess Functional Impairment in People with Depression: Should Employment Receive More Attention?
por: Chiang, Yu-Chen, et al.
Publicado: (2021)

WHODAS measurement properties for women with dysmenorrhea
por: de Arruda, Guilherme Tavares, et al.
Publicado: (2023)

The World Health Organization Disability Assessment Schedule-2.0 (WHODAS 2.0) in a chronic pain population being considered for chronic opioid therapy
por: Wawrzyniak, Kelly M, et al.
Publicado: (2019)

Validation of the 36-item version of the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) for assessing women's disability and functioning associated with maternal morbidity
por: Silveira, Carla, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_679dk79fv4ki0k9mnt791skngv